Executive interview – Ergomed

Published on 10 December 2018

CEO Stephen Stamp discusses trends in the pharmacovigilance and clinical research markets as well as the current structure and focus of the business following the acquisition of PSR.

Share this with friends and colleagues

You may also be interested in these

pacla medical

Pacla Medical – executive interview

TMT
28 June 2022
cantargia

Cantargia – executive interview

Healthcare
24 June 2022
Vantage.jpg

Vantage: James Thorne on the smaller companies’ effect

Investment companies
24 June 2022

Vantage: Randy Baron on buying growth using the principles of a value investor

Investment companies
21 June 2022